medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2022, Number 2

<< Back

Acta Med 2022; 20 (2)

The wisdom of the kidney III. The adaptation of renal function to its progressive damage. The intact nephron hypothesis

Peña RJC

Language: Spanish
References: 23
Page: 207-217
PDF size: 263.42 Kb.


ABSTRACT

In this article, we present and analyzed the Intact Nephron Hypothesis that explains in part the great capacity of the diseased kidney, that after the destruction of thousands of nephrons and the loss of more than 80% of the renal function, the adaptive changes of the renal function were sufficient to maintain the body homeostasis with mild clinical symptoms. This saga began with the paper published by the eminent pathologist Jean Oliver "When is the kidney not a kidney". In this article, Dr. Oliver states: "The answer I will give in (this) question is, therefore, now apparent. There is no kidney, either structural or functional, in chronic kidney disease". Even though the loss of structural homogeneity, necessarily destroys the functional homogeneity. Dr. Bricker and other investigators believe that in the usual forms of chronic renal failure, a basic orderliness is conserved in the urine-forming nephrons. They studied the renal function with clearance methods in different models of kidney lesions in humans and animals, such as unilateral renal disease with one intact kidney, 5/6 nephrectomy, and induced Heyman's nephritis and other models. These studies demonstrated that the intact nephrons, maintained the sodium balance, the control of calcium and phosphorus equilibrium with the so-called "Trade-off hypothesis". The excretion of hydrogen and ammonium to maintain the acid-base balance. The potassium excretion and the concentration mechanism of the urine and other functions. The results of all these investigations are derived from the "Intact Nephron hypothesis" that explains the great adaptive functional capacity of the kidney.


REFERENCES

  1. Smith HW. The kidney: Structure and function in health and disease. Oxford University Press. 1951, 1041.

  2. Peña JC. In memoriam. Frederic C Bartter (1914-1983). Rev Invest Clin. 1983; 35 (5): 263-264.

  3. Oliver J. When is the kidney not a kidney. J Urol. 1950; 63: 373-402.

  4. Smith HW. Note on the interpretation of clearance methods in the diseased kidney. J Clin Invest. 1941; 20 (6): 631-635.

  5. Bricker NS, Morrin PA, Kime Jr SW. The pathologic physiology of chronic Bright's disease. An exposition of the "intact nephron hypothesis". Am J Med. 1960; 28: 77-98.

  6. Platt R. Structural and functional adaptation in renal failure. Br Med J. 1952; 21: 1313-1317.

  7. Smith WH. From fish to philosopher. Boston, Little Brown and Comp. 1933.

  8. Bricker NS, Klahr S, Lubowitz H, Rieselbach RE. Renal function in chronic renal failure. Medicine (Baltimore). 1965; 44: 263-288.

  9. Bricker NS. On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis". N Engl J Med. 1972; 286: 1093-1099.

  10. Slatopolsky E, Elkan IO, Weerts C, Bricker NS. Studies on the characteristics of the control system governing sodium excretion in uremic man. J Clin Invest. 1968; 47 (3): 521-530.

  11. De Wardener HE, Millls IH, Claphman WF, Hayter CJ. Studies on the efferent mechanism of sodium diuresis which follows the administration of intravenous saline in the dog. Clin Sci. 1961; 21: 249-258.

  12. Mohring J, Mohring B. Reevaluation of DOCA escape phenomenon. Am J Physiol. 1972; 223 (5): 1237-1245.

  13. Peña JC. Insuficiencia renal crónica. En: Peña JC. Nefrología clínica y trastornos del agua y los electrolitos. Editorial Méndez Editores 2009, Ciudad México. 411-425.

  14. Bricker NS, Kime SW Jr, Morrin PAF, Orlowski T. The influence of glomerular filtration rate, solute excretion and hydration on the concentrating mechanism of the experirmentally diseased kidney in the dog. J Clin Invest. 1960; 39 (6): 864-875.

  15. Coburn JW, Gonik HC, Rubini M, Kleeman CR. Concentrating and diluting ability of 5/6 nephrectomized dogs. A test of the intact nephron hypothesis of chronic renal disease. J Clin Invest. 1963; 11: 118.

  16. Ueda Y, Ookawara S, Ito K, Miyazawa H, Kaku Y, Hoshino T et al. Changes in urinary potassium excretion in patients with chronic kidney disease. Kidney Res Clin Pract. 2016; 35 (2): 78-83.

  17. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005; 16 (2): 520-528.

  18. Slatopolsky E. The intact nephron hypothesis: the concept and its implications for posphate management in GKD-related mineral and bone disorder. Kidney Int Suppl. 2011; 79 (Suppl. 121): S3-S8.

  19. Peña JC, Garcia Bravo l, Sierra Paramo R, Perez-Grovas H. Tratamiento del hiperparatiroidismo secundario grave, en pacientes con falla renal crónica en hemodiálisis, con 1 alfa hidroxivitamina D3 (alfacalcidiol). Nefrología Latinoamericana. 2001; 8: 10-20.

  20. Hamm LL, Nakhoul N, Hering-Smith KS. Acid-base homeostasis. Clin J Am Soc Nephrol. 2015; 10 (12): 2232-2242.

  21. Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol. 2010; 21 (11): 1819-1834.

  22. Zeisberg M, Kalluri R. Physiology of the renal interstitium. Clin J Am Soc Nephrol. 2015; 10 (10): 1831-1840.

  23. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013; 3 (1): 136-150.




2020     |     www.medigraphic.com